Ruxolitinib For The Treatment Of Inadequately Controlled Polycythemia Vera Without Splenomegaly: 156-Week Follow-Up From The Phase 3 Response-2 StudyFrancesco Passamonti,Francesca Palandri,Guray Saydam,Giulia Benevolo,Miklos Egyed,Jeannie Callum,Timothy Devos,Serdar Sivgin,Paola Guglielmelli,Alessandro M. Vannucchi,Caroline Bensasson,Albert Kandra,Juliane Morando,Martin GriesshammerBLOOD（2018）引用 3|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
